Hans-Jürgen Tiedtke
Directeur Technique/Scientifique/R&D chez IMI Intelligent Medical Implants AG
Profil
Hans-Jürgen Tiedtke is currently working as the Vice President-Technology at IMI Intelligent Medical Implants AG since 2009.
Previously, he worked as the Managing Director at HP-medica GmbH from 1992 to 2003.
He completed his undergraduate degree at RWTH Aachen University.
Postes actifs de Hans-Jürgen Tiedtke
| Sociétés | Poste | Début |
|---|---|---|
IMI Intelligent Medical Implants AG
 IMI Intelligent Medical Implants AG Medical DistributorsDistribution Services IMI Intelligent Medical Implants is a medical technology company. The goal of the company is to develop and market an intelligent retinal implant system for degenerative retinal disorders such as Retinitis Pigmentosa or Macular Degeneration and thereby make a contribution to the improvement of the quality of life of blind people. Through the combination of innovative technology from the medical device, IT and micro systems fields, a new class of active medical products has been created allowing, amongst other things, blind people to regain modest visual perception. The company was founded in 2002 and has 30 employees. The company has a process oriented quality management system in accordance with ISO 13485. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Hans-Jürgen Tiedtke
| Sociétés | Poste | Fin |
|---|---|---|
| HP-medica GmbH | President | 01/01/2003 |
Formation de Hans-Jürgen Tiedtke
| RWTH Aachen University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
IMI Intelligent Medical Implants AG
IMI Intelligent Medical Implants AG Medical DistributorsDistribution Services IMI Intelligent Medical Implants is a medical technology company. The goal of the company is to develop and market an intelligent retinal implant system for degenerative retinal disorders such as Retinitis Pigmentosa or Macular Degeneration and thereby make a contribution to the improvement of the quality of life of blind people. Through the combination of innovative technology from the medical device, IT and micro systems fields, a new class of active medical products has been created allowing, amongst other things, blind people to regain modest visual perception. The company was founded in 2002 and has 30 employees. The company has a process oriented quality management system in accordance with ISO 13485. | Distribution Services |
| HP-medica GmbH |